[go: up one dir, main page]

Huang et al., 2020 - Google Patents

Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism

Huang et al., 2020

View HTML
Document ID
5209081962212633067
Author
Huang C
Lee B
Liu K
Chang Y
Wu V
Lee P
Chang C
TAIPAI Study Group
et al.
Publication year
Publication venue
Journal of the Formosan Medical Association

External Links

Snippet

Background/purpose The aim of this study was to predict outcomes of adrenalectomy for unilateral primary aldosteronism (PA) using non-stimulated adrenal venous sampling (AVS) indices and the standardized Primary Aldosteronism Surgical Outcome (PASO) criteria …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes

Similar Documents

Publication Publication Date Title
Turcu et al. Primary aldosteronism—a multidimensional syndrome
Libianto et al. Detecting primary aldosteronism in Australian primary care: a prospective study
Kocjan et al. A new clinical prediction criterion accurately determines a subset of patients with bilateral primary aldosteronism before adrenal venous sampling
Vanni et al. Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thrombo-embolism lactate outcome study
Mathur et al. Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease
Amar et al. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism
Al-Khatib et al. Advancing research on the complex interrelations between atrial fibrillation and heart failure: a report from a US National Heart, Lung, and Blood Institute Virtual Workshop
Ahmad et al. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure
Angkananard et al. The association of serum magnesium and mortality outcomes in heart failure patients: a systematic review and meta-analysis
Wolley et al. Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?
Huang et al. Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism
Barge-Caballero et al. Beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy
Kobayashi et al. Magnetic resonance imaging–detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N‐terminal pro–brain natriuretic peptide levels
Kobayashi et al. Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling
Chee et al. Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralization
Kinugawa et al. Novel risk score efficiently prevents tolvaptan-induced hypernatremic events in patients with heart failure
Pan et al. Hemodynamic and non-hemodynamic components of cardiac remodeling in primary aldosteronism
Johnson et al. Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with bilateral adrenal masses
Hashimura et al. Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism
Rossi et al. Clinical management of primary aldosteronism: 2013 practical recommendations of the Italian Society of Hypertension (SIIA)
Kaur et al. Discordant imaging: adrenal vein sampling in almost half of patients with primary aldosteronism and a unilateral adrenal adenoma
Kobayashi et al. Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24‐h urinary aldosterone
Losurdo et al. Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events
Poppi et al. A prospective study of patients with refractory angina: outcomes and the role of high‐sensitivity troponin T
St‐Jean et al. Use of peripheral plasma aldosterone concentration and response to ACTH during simultaneous bilateral adrenal veins sampling to predict the source of aldosterone secretion in primary aldosteronism